Ghost Tree Capital, LLC Kiniksa Pharmaceuticals, Ltd. Transaction History

Ghost Tree Capital, LLC

  • $267 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 16, 2020
SELL
$15.21 - $25.53 $760,500 - $1.28 Million
-50,000 Closed
0 $0
Q2 2020

Aug 14, 2020
SELL
$15.08 - $26.0 $945,440 - $1.63 Million
-62,695 Reduced 55.63%
50,000 $1.27 Million
Q1 2020

May 15, 2020
SELL
$11.0 - $19.76 $2.61 Million - $4.69 Million
-237,305 Reduced 67.8%
112,695 $1.75 Million
Q4 2019

Feb 14, 2020
BUY
$5.24 - $12.96 $1.83 Million - $4.54 Million
350,000 New
350,000 $3.87 Million

Others Institutions Holding KNSA

# of Institutions
8
Shares Held
1.95M
Call Options Held
0
Put Options Held
0
View Full List

About Kiniksa Pharmaceuticals, Ltd.

KNSA Quotes by TradingView
  • Ticker KNSA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 34,470,400
  • Market Cap $672M
  • Description
  • Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatm...
More about KNSA
Track This Portfolio

Track Ghost Tree Capital, LLC Portfolio

Follow Ghost Tree Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ghost Tree Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ghost Tree Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email